1. Home
  2. PMCB vs MGRX Comparison

PMCB vs MGRX Comparison

Compare PMCB & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.42

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Logo Mangoceuticals Inc.

MGRX

Mangoceuticals Inc.

HOLD

Current Price

$0.20

Market Cap

4.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMCB
MGRX
Founded
1996
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
4.2M
IPO Year
2001
2023

Fundamental Metrics

Financial Performance
Metric
PMCB
MGRX
Price
$0.42
$0.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
97.6K
★ 378.6K
Earning Date
12-17-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 55.17
EPS
N/A
★ N/A
Revenue
N/A
★ $456,021.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.30
$0.18
52 Week High
$1.51
$2.28

Technical Indicators

Market Signals
Indicator
PMCB
MGRX
Relative Strength Index (RSI) 61.27 31.17
Support Level $0.32 N/A
Resistance Level $0.77 $0.48
Average True Range (ATR) 0.06 0.03
MACD 0.01 0.00
Stochastic Oscillator 91.64 22.50

Price Performance

Historical Comparison
PMCB
MGRX

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

About MGRX Mangoceuticals Inc.

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Share on Social Networks: